Lifestyle Modification for Diabetic Neuropathy
(IMABIN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a personalized program of diet, physical activity, and balance exercises (lifestyle modification) can improve nerve function and balance in people with early-stage type 2 diabetes or prediabetes. The researchers aim to determine if these lifestyle changes can reduce symptoms like dizziness or cold feet and lower the risk of falls. Participants will follow a tailored plan of aerobic exercises and balance training to assess improvements in quality of life. This trial is suitable for individuals with impaired glucose regulation (early-stage diabetes or prediabetes) who experience symptoms such as dizziness, dry mouth, or balance issues.
As an unphased trial, this study provides an opportunity to contribute to understanding how lifestyle changes can improve health outcomes.
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications. However, if you are on diabetes medication, you need to have been stable on it for at least 3 months before joining the study.
What prior data suggests that this lifestyle modification is safe for improving autonomic function and balance in individuals with impaired glucose regulation?
Research has shown that lifestyle changes, such as diet and exercise, are generally safe and low-risk for individuals with diabetic nerve pain. Studies have found that these changes offer many benefits with minimal risk. Participants in these programs often experience improved health without serious side effects.
Exercise, particularly activities like walking or cycling, is associated with better nerve health and fewer complications. This type of exercise is safe and can help slow nerve damage.
Additionally, programs that incorporate exercise and dietary changes have proven helpful for people with diabetes, improving symptoms and overall health. These programs are tailored to each individual, making them both safe and effective for managing diabetic nerve pain.
In summary, lifestyle changes are well-tolerated and provide a safe way to potentially enhance health for those with diabetic nerve pain.12345Why are researchers excited about this trial?
Most treatments for diabetic neuropathy focus on managing symptoms with medications like pain relievers or antidepressants. However, researchers are excited about this trial because it emphasizes a holistic approach through lifestyle modification. The Diet, Physical Activity, and Balance Enhancement Program (DPAEP) is unique because it provides a personalized plan that combines structured weight loss, weight maintenance, and aerobic exercise tailored to individual needs. This approach not only targets weight and fitness but also aims to improve autonomic function, potentially offering benefits beyond what current medication can achieve. By focusing on meaningful, personalized activities and consistent support, this treatment could lead to improved overall health and quality of life for patients.
What evidence suggests that lifestyle modification might be an effective treatment for diabetic neuropathy?
Research has shown that lifestyle changes, such as exercising and eating a healthy diet, can aid individuals with diabetic nerve damage. In this trial, participants in the Diet, Physical Activity, and Balance Enhancement Program (DPAEP) group will follow a structured weight loss and aerobic exercise program. One study found that these changes can slow the progression of nerve damage in people with diabetes. Another study demonstrated that aerobic exercise, such as walking or cycling, can enhance nerve function. These lifestyle changes can also improve balance, which is crucial for preventing falls. Overall, these changes offer a promising approach to managing symptoms and improving the quality of life for those with early diabetes or blood sugar control issues.12367
Who Is on the Research Team?
James W Russell, MD
Principal Investigator
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Are You a Good Fit for This Trial?
This trial is for adults aged 30-80 with diabetic neuropathy due to impaired glucose regulation, including prediabetes and early diabetes. Participants must not be pregnant or imprisoned, have stable medical conditions, and agree to use contraception if applicable. They should not have severe autonomic neuropathy that limits participation in the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Testing
Participants undergo baseline testing before randomization into study groups
Treatment
Participants in the DPAEP group undergo a structured weight loss and maintenance program, along with aerobic exercise for 12 months. The SC group receives general diet and physical activity information.
Follow-up
Participants are monitored for changes in autonomic function and balance control after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- lifestyle modification
Trial Overview
The trial tests a Diet, Physical Activity, and Balance Enhancement Program (DPAEP) aimed at improving autonomic function and balance in people with impaired glucose regulation. It compares this intervention's effectiveness against standard care in preventing or reversing neuropathy.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Subjects in the DPAEP group will undergo a structured weight loss for approximately 6 months, followed by approximately 6 months of weight maintenance, as well as 12 months of aerobic exercise. This intervention stresses a personalized program emphasizing activities that are meaningful to and are tailored to individual participants; provides consistent contact between the participants and research staff; and allows monitoring of activity levels using questionnaires, actigraphy, monitoring of heart rate, direct and telephone contact. Participants dietary and physical activity goals as assessed by the dietician and trainer will be discussed at face-to face meetings to re-establish these goals. These programs will be tailored to meet the realistic goals of the individual participant. The program stresses aerobic exercise, rather than other types of exercise interventions, as aerobic exercise appears to correlate best with improved autonomic function.
The SC group will be assigned an interventionist assessor. This assessor will meet with the subjects during their orientation meeting and will be provided guidelines and a weight loss and physical activity target to achieve by the end of the program at their orientation meeting. Participants will contacted approximately weekly during the approximate 12 month period.
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
Published Research Related to This Trial
Citations
Physical Activity and Dietary Interventions in Diabetic ...
Physical activity and dietary interventions in patients with diabetes and diabetic neuropathy have multiple beneficial effects and are generally low risk.
Effects of a long-term lifestyle modification programme on ...
The aim of this study was to evaluate the effects on diabetic peripheral neuropathy (DPN) of a long-term intensive lifestyle intervention (ILI) programme
Role of Synchronized Lifestyle Modification Program on ...
In life style modification, variety of exercises are recommended that help to slow the progression of peripheral neuropathy.These include; aerobic training ...
Diabetic neuropathy: cutting-edge research and future ...
Collaborative care models enhance lifestyle interventions by focusing on diet, exercise, and foot care, essential for preventing complications ...
Effectiveness of exercise on musculoskeletal function and ...
Conclusion: The available evidence suggests that exercise training is an effective method for improving peripheral neuropathy. Systematic review ...
Lifestyle and the Prevention of Type 2 Diabetes: A Status ...
For instance, ≥2.5 h/wk of moderate-intensity brisk walking is associated with a diabetes risk reduction of 27%, independent of BMI. Furthermore, moderate- to ...
Effects of a long-term lifestyle modification programme on ...
The aim of this study was to evaluate the effects on diabetic peripheral neuropathy (DPN) of a long-term intensive lifestyle intervention (ILI) programme
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.